Contact
searchSearch
HMP Global

Demodex Blepharitis Topic Center

Industry Insights
News
Expert Perspectives
Videos

news


News
Increased Understanding of Rosacea Pathogenesis Leads to An Increase in Therapeutic Options
05/30/2024
Lisa Kuhns, PhD, MD
Rosacea imposes a substantial burden on both patients and the economy, and further research is needed to better understand its pathogenesis and develop new treatments, according to an article published in Frontiers in Medicine.
Rosacea imposes a substantial burden on both patients and the economy, and further research is needed to better understand its pathogenesis and develop new treatments, according to an article published in Frontiers in Medicine.
Rosacea imposes a substantial...
05/30/2024
First Report Managed Care
News
Demodex Mites Detected in 80% of Patients With Rosacea
05/22/2024
Jolynn Tumolo
A dermoscopic evaluation detected Demodex mites in 80% of patients with rosacea compared with just 20% of patients in a control group, researchers reported in a study published in the journal Northern Clinics of Istanbul.
A dermoscopic evaluation detected Demodex mites in 80% of patients with rosacea compared with just 20% of patients in a control group, researchers reported in a study published in the journal Northern Clinics of Istanbul.
A dermoscopic evaluation...
05/22/2024
First Report Managed Care
News
Keratoconus Appears to be Associated With Demodex Mites
05/16/2024
Jolynn Tumolo
Keratoconus, an eye disorder that leads to gradual curvature of the cornea, may be associated with Demodex infestation, suggests a small study published in the Oman Journal of Ophthalmology.
Keratoconus, an eye disorder that leads to gradual curvature of the cornea, may be associated with Demodex infestation, suggests a small study published in the Oman Journal of Ophthalmology.
Keratoconus, an eye disorder...
05/16/2024
First Report Managed Care
News
Demodex Infestation Found in 9 of 10 Eye Clinic Patients Using 2-Minute Technique
05/09/2024
Jolynn Tumolo
Demodex mites were found in the eyelashes of 94% of patients examined with a simple diagnostic technique at a standard ophthalmic practice, according to a study published online in the journal Clinical Ophthalmology.
Demodex mites were found in the eyelashes of 94% of patients examined with a simple diagnostic technique at a standard ophthalmic practice, according to a study published online in the journal Clinical Ophthalmology.
Demodex mites were found in the...
05/09/2024
First Report Managed Care
News
Chicago Sky Blue May be Considered as a Diagnostic Stain for Visualizing Demodex in Patients With Demodex Blepharitis
04/24/2024
Lisa Kuhns, PhD, MD
Chicago sky blue is a promising stain that can identify and quantify the number of Demodex mites in patients with Demodex blepharitis, according to a study published in PeerJ.
Chicago sky blue is a promising stain that can identify and quantify the number of Demodex mites in patients with Demodex blepharitis, according to a study published in PeerJ.
Chicago sky blue is a promising...
04/24/2024
First Report Managed Care
News
Study Finds Less Bacterial Diversity in Lashes of Patients With Demodex Blepharitis
04/11/2024
Jolynn Tumolo
Bacterial diversity is decreased in the eyelashes of patients with Demodex blepharitis compared with healthy volunteers, according to a study published online in Parasites & Vectors.
Bacterial diversity is decreased in the eyelashes of patients with Demodex blepharitis compared with healthy volunteers, according to a study published online in Parasites & Vectors.
Bacterial diversity is decreased...
04/11/2024
First Report Managed Care
News
Recommendations for Diagnosing and Managing Demodex Blepharitis are Presented in a New Study
04/05/2024
Lisa Kuhns, PhD, MD
An expert panel proposed a pragmatic approach to diagnose and manage Demodex blepharitis in a recent study published in Eye.
An expert panel proposed a pragmatic approach to diagnose and manage Demodex blepharitis in a recent study published in Eye.
An expert panel proposed a...
04/05/2024
First Report Managed Care
News
Meta-Analysis Finds Lotilaner Superior to Vehicle for Demodex Blepharitis
04/02/2024
Jolynn Tumolo
Treatment with lotilaner ophthalmic solution 0.25% was superior to vehicle/control for all Demodex blepharitis outcomes in a systematic review and meta-analysis published online in Cureus.
Treatment with lotilaner ophthalmic solution 0.25% was superior to vehicle/control for all Demodex blepharitis outcomes in a systematic review and meta-analysis published online in Cureus.
Treatment with lotilaner...
04/02/2024
First Report Managed Care
News

Delphi Methodology Establishes Consensus About Demodex Blepharitis Signs, Symptoms, and Diagnosis
12/15/2023
Lisa Kuhns, PhD, MD
The Delphi methodology effectively establishes consensus on the diagnosis of Demodex blepharitis (DB), including signs and symptoms, but does not determine the best course of treatment or how to grade the severity of the disease, according to...
The Delphi methodology effectively establishes consensus on the diagnosis of Demodex blepharitis (DB), including signs and symptoms, but does not determine the best course of treatment or how to grade the severity of the disease, according to...
The Delphi methodology...
12/15/2023
First Report Managed Care
News
The Toxic Effects of Tea Tree Oil for Treatment of Demodex Mites
11/16/2023
Hannah Musick
“Our findings show that T4O causes a dose- and time-dependent decrease in cell survival of immortalized human meibomian gland epithelial cells,” said researchers.
“Our findings show that T4O causes a dose- and time-dependent decrease in cell survival of immortalized human meibomian gland epithelial cells,” said researchers.
“Our findings show that T4O...
11/16/2023
First Report Managed Care

Behind the Bill

Behind the Bill
The Senate’s $3 Trillion Deal. Tax Relief Now, Medicaid Coverage Loss Later?
07/02/2025
Katie Hayes, MJ
The Senate has done it. After weeks of behind-the-scenes wrangling and last-minute amendments, lawmakers have passed a sprawling tax-and-spending megabill that makes good on a long-standing Republican goal: making the 2017 Trump tax cuts...
The Senate has done it. After weeks of behind-the-scenes wrangling and last-minute amendments, lawmakers have passed a sprawling tax-and-spending megabill that makes good on a long-standing Republican goal: making the 2017 Trump tax cuts...
The Senate has done it. After...
07/02/2025
First Report Managed Care
Behind the Bill
When a Cap Isn’t Just a Cap: How a Provider Tax Proposal Could Reshape Medicaid Financing
06/25/2025
Katie Hayes, MJ
In Washington, the most consequential policies are often buried in the fine print. One such detail in the Senate Finance Committee’s latest tax and spending proposal would gradually cap provider taxes—a core funding tool states use to pull in...
In Washington, the most consequential policies are often buried in the fine print. One such detail in the Senate Finance Committee’s latest tax and spending proposal would gradually cap provider taxes—a core funding tool states use to pull in...
In Washington, the most...
06/25/2025
First Report Managed Care
Behind the Bill
Rewriting the Safety Net? Inside the Senate’s Changes to Medicaid and the ACA
06/18/2025
Katie Hayes, MJ
Over the past few weeks, I’ve been following the progress of the One Big Beautiful Bill Act (OBBBA), which started in the House with sweeping tax reforms and some eye-catching health care proposals. Now, the Senate has released its (highly...
Over the past few weeks, I’ve been following the progress of the One Big Beautiful Bill Act (OBBBA), which started in the House with sweeping tax reforms and some eye-catching health care proposals. Now, the Senate has released its (highly...
Over the past few weeks, I’ve...
06/18/2025
First Report Managed Care
Behind the Bill
How States Might Respond to the One Big Beautiful Bill Act
06/11/2025
Katie Hayes, MJ
With the One Big Beautiful Bill Act (OBBBA) still in the hands of the Senate, much of the national conversation has centered on what this legislation would do to federal coverage programs. But regardless of how the federal process unfolds,...
With the One Big Beautiful Bill Act (OBBBA) still in the hands of the Senate, much of the national conversation has centered on what this legislation would do to federal coverage programs. But regardless of how the federal process unfolds,...
With the One Big Beautiful Bill...
06/11/2025
First Report Managed Care
Behind the Bill
Is the Affordable Care Act on the Chopping Block? What the One Big Beautiful Bill Act Tells Us.
06/04/2025
Katie Hayes, MJ
It’s been weeks of headline-grabbing debate over Medicaid work requirements, and the “One Big Beautiful Bill Act” remains in the Senate as they deliberate over several health care provisions. While the Medicaid provisions sparked most of the...
It’s been weeks of headline-grabbing debate over Medicaid work requirements, and the “One Big Beautiful Bill Act” remains in the Senate as they deliberate over several health care provisions. While the Medicaid provisions sparked most of the...
It’s been weeks of...
06/04/2025
First Report Managed Care
Behind the Bill
From House to Senate: The Journey of Cutting Medicaid
05/28/2025
Katie Hayes, MJ
Last week, the House of Representatives narrowly passed the One Big Beautiful Bill Act (HR 1, 119th Congress) by a single vote, sending the sweeping tax and spending reconciliation package, backed by President Trump, to the Senate. With its...
Last week, the House of Representatives narrowly passed the One Big Beautiful Bill Act (HR 1, 119th Congress) by a single vote, sending the sweeping tax and spending reconciliation package, backed by President Trump, to the Senate. With its...
Last week, the House of...
05/28/2025
First Report Managed Care
Behind the Bill
Eligibility, Paperwork, and Penalties: The Not-So-Hidden Costs of Medicaid ‘Reform’
05/21/2025
Katie Hayes, MJ
It’s been another eventful week in health policy—a phrase that’s quickly becoming routine. This time, House Republicans advanced a sweeping budget reconciliation bill, designed to implement elements of the March budget resolution, with a...
It’s been another eventful week in health policy—a phrase that’s quickly becoming routine. This time, House Republicans advanced a sweeping budget reconciliation bill, designed to implement elements of the March budget resolution, with a...
It’s been another eventful week...
05/21/2025
First Report Managed Care
Behind the Bill
A Busy Week in Drug Pricing Policy: Aligning US Drug Prices With Global Standards?
05/14/2025
Katie Hayes, MJ
It’s been a busy few days for drug pricing policy. While I’d love to dig into the details of both President Trump’s latest executive order and the newest Republican bill that would cut Medicaid spending, we don’t have the time—and this isn’t...
It’s been a busy few days for drug pricing policy. While I’d love to dig into the details of both President Trump’s latest executive order and the newest Republican bill that would cut Medicaid spending, we don’t have the time—and this isn’t...
It’s been a busy few days for...
05/14/2025
First Report Managed Care
BEHIND THE BILL
When Agencies Lose Power: How 3 Seismic Shifts are Transforming Pharmaceutical Regulation
05/07/2025
Katie Hayes, MJ
In the span of just 9 months, the landscape of administrative law has undergone a transformation so profound that pharmaceutical executives, health care providers, and patients alike are struggling to navigate the new terrain. The Supreme...
In the span of just 9 months, the landscape of administrative law has undergone a transformation so profound that pharmaceutical executives, health care providers, and patients alike are struggling to navigate the new terrain. The Supreme...
In the span of just 9 months,...
05/07/2025
First Report Managed Care
Behind the Bill
The Medicare Paradox, Part 3: Strategic Trade Doesn’t Have to be a Zero-Sum Game
05/07/2025
Katie Hayes, MJ
Over the past 2 weeks, I’ve examined the growing friction between the Section 232 pharmaceutical tariff investigations and the Medicare drug pricing reforms authorized by the Inflation Reduction Act (IRA). These 2 policy agendas—industrial...
Over the past 2 weeks, I’ve examined the growing friction between the Section 232 pharmaceutical tariff investigations and the Medicare drug pricing reforms authorized by the Inflation Reduction Act (IRA). These 2 policy agendas—industrial...
Over the past 2 weeks, I’ve...
05/07/2025
First Report Managed Care

Subscribe and Stay Ahead With Daily Industry Insights

First Report Managed Care Newsletter

Trending Articles

News
Online Screening Bridges Mental Health Care Gaps in Underserved Rural Communities, Study Finds
10/17/2023
Lisa Kuhns, PhD, MD
Online screening is a vital tool in bridging mental health care gaps in rural, resource-deficient communities, according to a study published in the Journal of Psychiatric Research.
Online screening is a vital tool in bridging mental health care gaps in rural, resource-deficient communities, according to a study published in the Journal of Psychiatric Research.
Online screening is a vital tool...
10/17/2023
First Report Managed Care
News
Analysis Finds Similar Safety Profile with Upadacitinib Across Conditions
11/03/2023
Jolynn Tumolo
The Janus kinase (JAK) inhibitor upadacitinib offers a similar long-term safety profile across rheumatoid arthritis (RA), psoriatic arthritis (PsA), ankylosing spondylitis (AS), and atopic dermatitis (AD) despite some variations in adverse...
The Janus kinase (JAK) inhibitor upadacitinib offers a similar long-term safety profile across rheumatoid arthritis (RA), psoriatic arthritis (PsA), ankylosing spondylitis (AS), and atopic dermatitis (AD) despite some variations in adverse...
The Janus kinase (JAK) inhibitor...
11/03/2023
First Report Managed Care
News
Research Indicates Biosimilar-to-Biosimilar Switching in Chronic Inflammatory Diseases Safe
12/04/2023
Hannah Musick
Research indicates that switching between biosimilars is safe and effective, supporting the use of biosimilars to decrease costs and improve access to biological medicines.
Research indicates that switching between biosimilars is safe and effective, supporting the use of biosimilars to decrease costs and improve access to biological medicines.
Research indicates that...
12/04/2023
First Report Managed Care
News
Subthreshold Micropulse Laser Equivalent to Standard Laser Therapy for DME
01/10/2024
Jolynn Tumolo
Subthreshold micropulse laser therapy was comparable in both efficacy and cost to standard laser therapy in patients with diabetic macular edema (DME) with central retinal thickness less than 400 μm, according to a noninferiority trial...
Subthreshold micropulse laser therapy was comparable in both efficacy and cost to standard laser therapy in patients with diabetic macular edema (DME) with central retinal thickness less than 400 μm, according to a noninferiority trial...
Subthreshold micropulse laser...
01/10/2024
First Report Managed Care
Yash Prajapati
Videos
Navigating the Evolution of Digital Solutions in Health Care
02/27/2024

Featuring Yash Prajapati, consultant at ZS Associates 

Featuring Yash Prajapati, consultant ...
Join us in exploring the challenges and opportunities in the development, approval, and integration of digital therapeutic solutions with ZS Associates consultant Yash Prajapati.
Join us in exploring the challenges and opportunities in the development, approval, and integration of digital therapeutic solutions with ZS Associates consultant Yash Prajapati.
Join us in exploring the...
02/27/2024
First Report Managed Care

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2025 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use